AI Skin Cancer Tools: The Metric That Matters Now Is Clinical Value
A Frontiers analysis argues AI skin cancer diagnostics must now prove clinical value — real outcomes, not benchmark accuracy — as tools move into practice.
Topic
Diagnostic Accuracy
Topic
Diagnostic Accuracy
VisualDx CEO Flags Decades-Old Diagnostic Blind Spot in Skin of Color
At Fall Clinical Derm 2026, VisualDx's CEO spotlighted a decades-old blind spot in diagnosing disease on skin of color, pressing…